Skip to content

Author

Ning Li

We have 3 of 41 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Oct 2026

Guaianolide-type sesquiterpenes from Rhaponticum repens (L.) Hidalgo with anti-ischemic stroke activity.

Ischemic stroke (IS) is a severe central nervous system disorder with high mortality and disability rates, and microglia-mediated neuroinflammation exacerbates ischemic brain injury. In this study, the traditional ethnic medicine Rhaponticum repens (L.) Hidalgo was found to significantly inhibit lipopolysaccharide (LPS...

Ye-Wen Jia, Wen Dang, Jia-Yi Du et al. · 0 citations
Oct 2026

Discovery of novel CDK9 inhibitors containing 1H-pyrrolo[2,3-b]pyridine moiety for treatment of colorectal cancer.

Mechanistic studies and in vivo experiments demonstrated that intravenous injection of compound B3 could achieve prominent therapeutic efficacy with a high safety profile and indicate that compound B3 is a promising candidate for CRC treatment.

Ye Zhong, Jing Xu, Lian-Zhe Zhang et al. · 0 citations
Review Aug 2026

[Pharmacological effects, biosynthesis, and production of coumarin compounds: a review].

The pharmacological effects, biosynthetic pathways, and biomanufacturing methods of different types of coumarins are reviewed, providing important references for the green, efficient, and sustainable production of coumarins, and are conducive to promoting the development of new coumarin-based drugs.

Wang-Bin Chen, Jia-Zeng Yang, Ning Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.